Transactions
2
Insider / Bluejay Diagnostics, Inc.
CHASE DONALD R
Director at Bluejay Diagnostics, Inc.
- Company
- Bluejay Diagnostics, Inc.
- Ticker
- BJDX
- First filing on record
- May 18, 2026
- Latest trade on record
- August 17, 2026
- SEC filings
- EDGAR ↗
CHASE DONALD R, Director at Bluejay Diagnostics, Inc., has disclosed 2 transactions in BJDX since May 18, 2026: 1 purchase (1 open-market buy) and 0 sales, worth about $25K at the reported prices. The latest was filed August 18, 2026, 1 day after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
1
Sales
0
Avg. disclosure lag
33.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months CHASE DONALD R made 1 purchase worth $25K and no sales, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
CHASE DONALD R has traded 1 stock on record; the largest by dollars is BJDX.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 100,000 | — |
| P | Open-market purchase | 1 | 12,500 | $25K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 1 · $25K | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| BJDX | Other A | August 17, 2026 | August 18, 2026 | 1d | 100,000 | — | — | derivative | Form 4 ↗ | |
| BJDX | Buy P | March 14, 2026 | May 18, 2026 | 65d | 12,500 | $2 | $25K | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 18, 2026 | Form 4 | 0001123292-26-001123 | 1 | published | EDGAR ↗ |
| May 18, 2026 | Form 4 | 0001123292-26-000688 | 1 | published | EDGAR ↗ |
Other insiders at Bluejay Diagnostics, Inc.
- BANK OF AMERICA CORP /DE/ Insider 422 rows
- Dey Indranil President and CEO 2 rows
- Dey Svetlana Director 2 rows
- HRT FINANCIAL LP Insider 2 rows
- Wurth Douglas Clark Director 2 rows
- ZEIDMAN FRED S Director 2 rows
Everyone on file, with contracts and lobbying under the company's name: Bluejay Diagnostics, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 2 | May 18, 2026 | August 18, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.